Literature DB >> 3973511

Human apolipoprotein A-IV: displacement from the surface of triglyceride-rich particles by HDL2-associated C-apoproteins.

R B Weinberg, M S Spector.   

Abstract

Human apolipoprotein A-IV rapidly dissociates from the surface of lymph chylomicrons following their entry into circulation by an unknown mechanism. We have therefore investigated the binding of human apoA-IV to triglyceride-rich particles and the interaction of these apoA-IV/lipid complexes with human HDL2. Human apoA-IV was purified from lipoprotein depleted serum (J. Lipid Res. 1983. 24:52-59). Triglyceride-rich particles of well-defined properties were isolated from Intralipid, a commercially available phospholipid-triglyceride emulsion. Various concentrations of radiolabeled human apoA-IV were incubated at 24 degrees C with a fixed quantity of lipid particles; the particles were reisolated by centrifugation, and bound and free apoA-IV were quantitated. In 50 mM Tris, pH 7.4, apoA-IV bound to the triglyceride-rich particles in a non-cooperative manner, with a Kd of 2.0 microM. The calculated maximal binding was 4.96 X 10(-4) mol of apoA-IV bound per mol of phospholipid. The addition of increasing amounts of human HDL2 to the incubations caused the progressive dissociation of apoA-IV from the triglyceride-rich particles. Analysis of the reisolated particles by isoelectric focusing demonstrated the presence of C-apoproteins, suggesting their transfer from HDL2. Addition of purified apoC-III-1 to the incubations at concentrations equivalent to those present in HDL2 caused a similar dissociation of apoA-IV. HDL2 was modified to selectively remove C-apoproteins, without alteration of other physical characteristics. This modified HDL2 was four times less effective in causing apoA-IV dissociation. These results demonstrate that the lipid binding properties of human apoA-IV may be quantitatively examined using triglyceride-rich particles as model chylomicrons. This approach reproduces in vitro the dissociation of apoA-IV that occurs in vivo when mesenteric lymph chylomicrons enter the circulation, and suggests that the primary mechanism for this phenomenon is the transfer of C-apoproteins from high density lipoproteins to the triglyceride-rich particle surface. We hypothesize that this mechanism may play an important role in the modulation of chylomicron apoA-IV content in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973511

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Apolipoprotein C-I binds more strongly to phospholipid/triolein/water than triolein/water interfaces: a possible model for inhibiting cholesterol ester transfer protein activity and triacylglycerol-rich lipoprotein uptake.

Authors:  Nathan L Meyers; Libo Wang; Donald M Small
Journal:  Biochemistry       Date:  2012-02-02       Impact factor: 3.162

2.  Distinctive structure and interfacial activity of the human apolipoprotein A-IV 347S isoprotein.

Authors:  Richard B Weinberg; Victoria R Cook
Journal:  J Lipid Res       Date:  2010-06-16       Impact factor: 5.922

3.  Hypercholesterolaemia treated by soybean protein diet.

Authors:  A Gaddi; G C Descovich; G Noseda; C Fragiacomo; A Nicolini; G Montanari; G Vanetti; M Sirtori; E Gatti; C R Sirtori
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

4.  A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry.

Authors:  Matthew R Tubb; R A Gangani D Silva; Jianwen Fang; Patrick Tso; W Sean Davidson
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

5.  Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Kyu Yeon Hur; Ann-Hwee Lee
Journal:  J Lipid Res       Date:  2014-03-05       Impact factor: 5.922

Review 6.  CREBH Regulates Systemic Glucose and Lipid Metabolism.

Authors:  Yoshimi Nakagawa; Hitoshi Shimano
Journal:  Int J Mol Sci       Date:  2018-05-08       Impact factor: 5.923

7.  Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis.

Authors:  Xiaohong Ruby Xu; Yiming Wang; Reheman Adili; Lining Ju; Christopher M Spring; Joseph Wuxun Jin; Hong Yang; Miguel A D Neves; Pingguo Chen; Yan Yang; Xi Lei; Yunfeng Chen; Reid C Gallant; Miao Xu; Hailong Zhang; Jina Song; Peifeng Ke; Dan Zhang; Naadiya Carrim; Si-Yang Yu; Guangheng Zhu; Yi-Min She; Terry Cyr; Wenbin Fu; Guoqing Liu; Philip W Connelly; Margaret L Rand; Khosrow Adeli; John Freedman; Jeffrey E Lee; Patrick Tso; Patrizia Marchese; W Sean Davidson; Shaun P Jackson; Cheng Zhu; Zaverio M Ruggeri; Heyu Ni
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.